Nrf2 Activity as a Potential Biomarker for the Pan-Epigenetic Anticancer Agent, RRx-001

Oncotarget - United States
doi 10.18632/oncotarget.4249
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Epigenetic Effects of RRx-001: A Possible Unifying Mechanism of Anticancer Activity

Oncotarget
Oncology
2015English

Platelet Inhibitory Effects of the Phase 3 Anticancer and Normal Tissue Cytoprotective Agent, RRx-001

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

5‑Hydroxymethylcytosine as a Potential Epigenetic Biomarker in Papillary Thyroid Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

A Maltol-Containing Ruthenium Polypyridyl Complex as a Potential Anticancer Agent

2019English

Honey as a Potential Natural Anticancer Agent: A Review of Its Mechanisms

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2013English

As a Potential Anticancer Agent, Raspberries May Be the "Pick of the Crop"

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1993English

RRx-001, an Epigenetic-Based Radio- And Chemosensitizer, Has Vascular Normalizing Effects on SCCVII and U87 Tumors

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2016English

Potential Anticancer Activity of Auranofin

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2019English

Anticancer Activity of Streptochlorin, a Novel Antineoplastic Agent, in Cholangiocarcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy